Pajjiż: Stati Uniti
Lingwa: Ingliż
Sors: NLM (National Library of Medicine)
VALSARTAN (UNII: 80M03YXJ7I) (VALSARTAN - UNII:80M03YXJ7I)
AvKARE, Inc.
VALSARTAN
VALSARTAN 40 mg
PRESCRIPTION DRUG
Abbreviated New Drug Application
VALSARTAN - VALSARTAN TABLET, FILM COATED AVKARE, INC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE VALSARTAN TABLETS SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR VALSARTAN TABLETS. VALSARTAN TABLETS, USP, FOR ORAL USE INITIAL U.S. APPROVAL: 1996 WARNING: FETAL TOXICITY _SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING._ WHEN PREGNANCY IS DETECTED, DISCONTINUE VALSARTAN TABLETS AS SOON AS POSSIBLE. (5.1) DRUGS THAT ACT DIRECTLY ON THE RENIN-ANGIOTENSIN SYSTEM CAN CAUSE INJURY AND EVEN DEATH TO THE DEVELOPING FETUS. (5.1) INDICATIONS AND USAGE Valsartan tablets, USP are an angiotensin II receptor blocker (ARB) indicated for: Treatment of HYPERTENSION, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions (1.1) Treatment of HEART FAILURE (NYHA class II-IV); valsartan tablets, USP significantly reduced hospitalization for heart failure (1.2) DOSAGE AND ADMINISTRATION * INDIC ATIO N STARTING DOSE DOSE RANGE T ARG E T MAINTENANCE DOSE Adult Hypertension (2.1) 80 or 160 mg once daily 80 to 320 mg once daily --- Pediatric Hypertension (6 to 16 years) (2.2) 1.3 mg/kg once daily (up to 40 mg total) 1.3 to 2.7 mg/kg once daily (up to 40 to 160 mg total) --- Heart Failure (2.3) 40 mg twice daily 40 to160 mg twice daily 160 mg twice daily DOSAGE FORMS AND STRENGTHS Tablets (mg): 40 (scored), 80, 160, 320 (3) CONTRAINDICATIONS Known hypersensitivity to any component; Do not coadminister aliskiren with valsartan tablets in patients with diabetes (4) WARNINGS AND PRECAUTIONS Observe for signs and symptoms of hypotension (5.2) Monitor renal function and potassium in susceptible patients (5.3, 5.4) ADVERSE REACTIONS HYPERTENSION: Most common adverse reactions are headache, dizziness, viral infection, fatigue and abdominal pain (6.1) HEART FAILURE: Most common adverse reactions are dizziness, hypotension, diarrhea, arthralgia, back pai Aqra d-dokument sħiħ